Fluxion Bio raises $6.9M for single-cell analysis
November 13, 2007 | David P. Hamilton
See our story about this San Francisco research-instrument maker in today’s daily briefing at VentureBeat Life Sciences.
Next Story: Angels do well, but not when they reinvest in own companies
Previous Story: CellFor raises $24.5M for cloned trees
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.












